NO20023771L - Pyrrolopyridazinforbindelse - Google Patents
PyrrolopyridazinforbindelseInfo
- Publication number
- NO20023771L NO20023771L NO20023771A NO20023771A NO20023771L NO 20023771 L NO20023771 L NO 20023771L NO 20023771 A NO20023771 A NO 20023771A NO 20023771 A NO20023771 A NO 20023771A NO 20023771 L NO20023771 L NO 20023771L
- Authority
- NO
- Norway
- Prior art keywords
- optionally substituted
- aryl
- carbonyloxymethyl
- cycloalkyl
- alkenyl
- Prior art date
Links
- -1 Pyrrolopyridazine compound Chemical class 0.000 abstract 4
- 239000003814 drug Substances 0.000 abstract 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- 208000025865 Ulcer Diseases 0.000 abstract 1
- 125000001931 aliphatic group Chemical group 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 abstract 1
- 210000004211 gastric acid Anatomy 0.000 abstract 1
- 210000001156 gastric mucosa Anatomy 0.000 abstract 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- ODUCDPQEXGNKDN-UHFFFAOYSA-N nitroxyl Chemical compound O=N ODUCDPQEXGNKDN-UHFFFAOYSA-N 0.000 abstract 1
- 125000005740 oxycarbonyl group Chemical group [*:1]OC([*:2])=O 0.000 abstract 1
- 230000000069 prophylactic effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000028327 secretion Effects 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
- 239000011593 sulfur Substances 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/5025—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000033627 | 2000-02-10 | ||
| PCT/JP2001/000820 WO2001058901A1 (fr) | 2000-02-10 | 2001-02-06 | Compose de pyrrolopyridazine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20023771D0 NO20023771D0 (no) | 2002-08-09 |
| NO20023771L true NO20023771L (no) | 2002-10-09 |
Family
ID=18558082
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20023771A NO20023771L (no) | 2000-02-10 | 2002-08-09 | Pyrrolopyridazinforbindelse |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US6734181B2 (ru) |
| EP (1) | EP1254907B1 (ru) |
| KR (1) | KR100750551B1 (ru) |
| CN (1) | CN1285593C (ru) |
| AT (1) | ATE361925T1 (ru) |
| AU (2) | AU3058501A (ru) |
| BR (1) | BR0108251A (ru) |
| CA (1) | CA2399380A1 (ru) |
| CZ (1) | CZ20022742A3 (ru) |
| DE (1) | DE60128329T2 (ru) |
| ES (1) | ES2286094T3 (ru) |
| HK (1) | HK1049163B (ru) |
| HU (1) | HUP0204579A3 (ru) |
| IL (1) | IL151167A0 (ru) |
| MX (1) | MXPA02007799A (ru) |
| NO (1) | NO20023771L (ru) |
| NZ (1) | NZ520606A (ru) |
| PL (1) | PL358014A1 (ru) |
| RU (1) | RU2254335C2 (ru) |
| WO (1) | WO2001058901A1 (ru) |
| ZA (1) | ZA200206196B (ru) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200418479A (en) * | 2002-09-25 | 2004-10-01 | Sankyo Co | Pharmaceutical compositions for the treatment or prevention of visceral pains |
| AU2003266622A1 (en) * | 2002-09-25 | 2004-04-19 | Sankyo Company, Limited | Medicinal composition for inhibiting increase in blood gastrin concentration |
| CN101361738A (zh) | 2003-11-03 | 2009-02-11 | 阿斯利康(瑞典)有限公司 | 治疗隐匿性胃食管反流的咪唑并[1,2-a]吡啶衍生物 |
| KR20070053231A (ko) * | 2004-07-28 | 2007-05-23 | 다케다 야쿠힌 고교 가부시키가이샤 | 피롤로[2,3-ｃ]피리딘 화합물, 그 제조 방법 및 용도 |
| WO2006038773A1 (en) * | 2004-09-03 | 2006-04-13 | Yuhan Corporation | Pyrrolo[3,2-b]pyridine derivatives and processes for the preparation thereof |
| CN101003537A (zh) * | 2006-01-17 | 2007-07-25 | 上海恒瑞医药有限公司 | 吡咯并哒嗪类衍生物及其制备方法和用途 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU7754691A (en) | 1990-04-27 | 1991-11-27 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Novel pyridazines |
| WO1992006979A1 (de) | 1990-10-15 | 1992-04-30 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Neue diazine |
| ATE179419T1 (de) * | 1991-10-25 | 1999-05-15 | Byk Gulden Lomberg Chem Fab | Pyrrolo-pyridazine mit magen- und darmschutzwirkungen |
| JP3143571B2 (ja) * | 1994-01-19 | 2001-03-07 | 三共株式会社 | ピロロピリダジン誘導体 |
| ATE229020T1 (de) * | 1994-01-19 | 2002-12-15 | Sankyo Co | Pyrrolopyridazin-derivate |
| US5753664A (en) | 1995-03-16 | 1998-05-19 | Takeda Chemical Industries, Ltd. | Heterocyclic compounds, their production and use |
| JPH0995485A (ja) * | 1995-03-16 | 1997-04-08 | Takeda Chem Ind Ltd | 複素環化合物、その製造法および剤 |
| TWI287014B (en) | 1999-06-15 | 2007-09-21 | Sankyo Co | Optically active pyrrolopyridazine compound |
-
2001
- 2001-02-06 CA CA002399380A patent/CA2399380A1/en not_active Abandoned
- 2001-02-06 EP EP01902778A patent/EP1254907B1/en not_active Expired - Lifetime
- 2001-02-06 KR KR1020027010327A patent/KR100750551B1/ko not_active IP Right Cessation
- 2001-02-06 HU HU0204579A patent/HUP0204579A3/hu unknown
- 2001-02-06 NZ NZ520606A patent/NZ520606A/en unknown
- 2001-02-06 AT AT01902778T patent/ATE361925T1/de not_active IP Right Cessation
- 2001-02-06 AU AU3058501A patent/AU3058501A/xx active Pending
- 2001-02-06 IL IL15116701A patent/IL151167A0/xx unknown
- 2001-02-06 RU RU2002121482/04A patent/RU2254335C2/ru not_active IP Right Cessation
- 2001-02-06 AU AU2001230585A patent/AU2001230585B2/en not_active Ceased
- 2001-02-06 BR BR0108251-5A patent/BR0108251A/pt not_active IP Right Cessation
- 2001-02-06 MX MXPA02007799A patent/MXPA02007799A/es active IP Right Grant
- 2001-02-06 WO PCT/JP2001/000820 patent/WO2001058901A1/ja active IP Right Grant
- 2001-02-06 DE DE60128329T patent/DE60128329T2/de not_active Expired - Fee Related
- 2001-02-06 PL PL01358014A patent/PL358014A1/xx not_active Application Discontinuation
- 2001-02-06 ES ES01902778T patent/ES2286094T3/es not_active Expired - Lifetime
- 2001-02-06 CN CNB018076513A patent/CN1285593C/zh not_active Expired - Fee Related
- 2001-02-06 CZ CZ20022742A patent/CZ20022742A3/cs unknown
-
2002
- 2002-08-02 ZA ZA200206196A patent/ZA200206196B/xx unknown
- 2002-08-08 US US10/215,246 patent/US6734181B2/en not_active Expired - Fee Related
- 2002-08-09 NO NO20023771A patent/NO20023771L/no not_active Application Discontinuation
-
2003
- 2003-02-20 HK HK03101293.9A patent/HK1049163B/zh not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| NZ520606A (en) | 2004-06-25 |
| KR20020072579A (ko) | 2002-09-16 |
| CA2399380A1 (en) | 2001-08-16 |
| CN1422272A (zh) | 2003-06-04 |
| CN1285593C (zh) | 2006-11-22 |
| HUP0204579A3 (en) | 2006-01-30 |
| NO20023771D0 (no) | 2002-08-09 |
| WO2001058901A1 (fr) | 2001-08-16 |
| KR100750551B1 (ko) | 2007-08-20 |
| HK1049163B (zh) | 2007-09-28 |
| EP1254907A1 (en) | 2002-11-06 |
| ES2286094T3 (es) | 2007-12-01 |
| DE60128329D1 (de) | 2007-06-21 |
| ATE361925T1 (de) | 2007-06-15 |
| CZ20022742A3 (cs) | 2003-02-12 |
| RU2254335C2 (ru) | 2005-06-20 |
| IL151167A0 (en) | 2003-04-10 |
| AU2001230585B2 (en) | 2005-01-06 |
| US20040014762A1 (en) | 2004-01-22 |
| DE60128329T2 (de) | 2008-01-10 |
| HUP0204579A2 (hu) | 2003-04-28 |
| HK1049163A1 (en) | 2003-05-02 |
| EP1254907B1 (en) | 2007-05-09 |
| RU2002121482A (ru) | 2004-01-10 |
| EP1254907A4 (en) | 2004-11-24 |
| MXPA02007799A (es) | 2002-10-17 |
| BR0108251A (pt) | 2003-03-25 |
| PL358014A1 (en) | 2004-08-09 |
| ZA200206196B (en) | 2003-11-03 |
| AU3058501A (en) | 2001-08-20 |
| US6734181B2 (en) | 2004-05-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL1685142T3 (pl) | Pochodne kwasu fosfinowego, inhibitory beta-sekterazy do leczenia choroby Alzheimera | |
| NO20051600L (no) | 1,4-disubstituerte piperidinderivater og anvendelse derav som 11-betaHSD1 inhibitorer | |
| HUP0400202A2 (hu) | Metalloproteináz inhibitor, hatású imidazolidin-dion-származékok alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények | |
| NO20055565L (no) | Anvendelse av derivater av 2,4-dihydro-[1,2,4]triazol-3-thion som inhibitorer av enzymet myeloperoksidase (MPO) | |
| NO20052802L (no) | Pyrrolopyrimidinderivativer | |
| WO2001064639A3 (en) | Pde iv inhibiting amides, compositions and pharmaceutical use | |
| NO20060376L (no) | Fremgangsmater for fremstilling av 1-[(benzotmidazol-l-yl)quinolm-8-yl]piperidin-4-ylamin-derivater | |
| AU7517400A (en) | N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent | |
| HUP0302479A2 (hu) | NF-kappa B gátló gyógyszerkészítmény, amely hatóanyagként helyettesített benzoesavszármazékot tartalmaz | |
| WO2001064645A3 (en) | Derivatives of quinoline as alpha-2 antagonists | |
| TW200420545A (en) | 1-(4-benzyl-piperazin-1-yl)-3-phenyl-propenone derivatives | |
| WO2005058228A3 (en) | Comt inhibitors | |
| NO20023771L (no) | Pyrrolopyridazinforbindelse | |
| HUP0301695A2 (hu) | Eljárás [(aril-acetil)-amino]-tiazolok előállítására | |
| NO20063012L (no) | Fremgangsmaten for syntesen av perindopril og farmasoytisk akseptable salter derav | |
| NO20053726L (no) | Forbindelser med prolyloligopeptidase-hemmende aktivitet | |
| ATE358128T1 (de) | Vorbeugende oder therapeutische mittel gegen gastrische oder ösophageale regurgitation | |
| DE60002860D1 (de) | Optisch aktive pyrrolopyridazin-derivate | |
| TW200612912A (en) | Benzyloxy derivatives as maob inhibitors | |
| MXPA04000485A (es) | Uso de acidos aril o heteroaril hidroxamicos de sulfonilo y derivados de los mismos como inhibidores de agrecanasa. | |
| NO20061152L (no) | Ny fremgangsmate for syntese av N-(S)-1-karboksybuty)-(S)-alanin og anvendelse derav for a syntetisere perindopril | |
| WO2003104189A3 (en) | COMPOUNDS | |
| US6541495B1 (en) | Carboxylic acid derivatives as inhibitors of hyperproliferation diseases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |